Physician profile
Elsa Thomas
NPI 1801878491
$1,121.31
in general payments reported to CMS, 2019-2025
18 companies · $203 in 2025
The $203 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $117 · 2022: $66.36 · 2023: $274 · 2024: $461 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $938.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $937.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $327.14 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Shionogi INC | $117.00 | 2020 | |
| Abbott Laboratories | $98.73 | 2023-2025 | Freestyle Libre 3 |
| Otsuka America Pharmaceutical, INC. | $75.01 | 2024-2025 | Jynarque |
| Glaxosmithkline, LLC. | $66.00 | 2022-2024 | Arexvy |
| Pfizer INC. | $64.21 | 2023-2025 | |
| Exact Sciences Corporation | $51.37 | 2023-2024 | Cologuard Collection Kit |
| Lilly USA, LLC | $49.61 | 2022-2025 | Zepbound, Mounjaro |
| Esperion Therapeutics, INC. | $45.57 | 2024-2025 | Nexletol |
| Abbvie INC. | $35.79 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $33.09 | 2023-2024 | Livalo |
| Eisai INC. | $31.13 | 2024 | |
| Inspire Medical Systems, INC. | $24.47 | 2025 | Inspire |
| Collegium Pharmaceutical, INC. | $23.77 | 2025 | Jornay Pm |
| Novartis Pharmaceuticals Corporation | $22.83 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $20.58 | 2024 | |
| Dynavax Technologies Corporation | $19.99 | 2022 | |
| Amgen INC. | $15.02 | 2024 | Repatha, Otezla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elsa Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.